Ameresco, Inc.

Thank you for standing by. My name is Jordan, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Q1 2026 Amoresco Inc. Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you'd like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you'd like to withdraw your question, press star one again. Thank you. I would now like to turn the call over to Leila Dillon, Chief Marketing Officer. Please go ahead.

Thank you, and good afternoon, everyone. We appreciate you joining us for today's call. Our speakers on the call today will be George Sakolaris, Amoresco's Chairman and Chief Executive Officer, Mike Backus, who will become the CEO of Neogenics Fuels, Nicole Bulgarino and Lou Maltesos, newly appointed co-presidents of Amoresco, and Mark Chiplock, Chief Financial Officer. In addition, Josh Barabo, our Chief Investment Officer, will also be available during Q&A to help answer questions. Before I turn the call over to George, I would like to make a brief statement regarding forward-looking remarks. Today's earnings materials contain forward-looking statements, including statements regarding our expectations. All forward-looking statements are subject to risks and uncertainties. In particular, some of the commentary is predicated on the expected closing of the neogenic fuels transaction. Please refer to today's earnings materials, the safe harbor language on slide two of our supplemental information, and our SEC filings for a discussion of the major risk factors that could cause our actual results to differ from those in our forward-looking statements. In addition, we use several non-GAAP measures when presenting our financial results. We have included the reconciliations of these measures and additional information in our supplemental slides that were posted to our website. Please note that all comparisons that we will be discussing today are on a year-over-year basis unless otherwise noted. I will now turn the call over to George.

George? Thank you, Lila. And good afternoon, everyone. I am pleased to report that we had a solid start to the year, with the MRESCO team delivering 14% revenue growth, despite experiencing adverse weather conditions affecting several of our RNG facilities. New business also remained quite strong, with 20% growth in awarded backlog. against a backdrop of significant activity, especially with the federal government. We also announced several important corporate actions which we have taken to better position ourselves for substantial future growth opportunities while also maximizing shareholder value. Today, after the market closed, we announced the signing of a transformational agreement with HACI for a $400 million strategic investment in our biofuels business. This agreement will create a newly formed joint venture named Neogenics Fuels. Embaresco has been a leader in the biofuels industry for the last 25 years. When completed, this transaction will enable us to monetize a portion of the $1.8 billion enterprise value that we have created in our biogas business. Of the $400 million commitment from CASI, $300 million will be directly invested in eugenics fuels to drive business growth. And the $100 million will be direct compensation to MRSCO for the existing business, which will be used for strategic opportunities, working capital, and the leveraging throughout the year. I would like to turn the call over to Mike Backus, a member of my management team for nearly 30 years, and who will become Chief Executive Officer of Neogenics Fuels. To comment on this exciting transaction, Mike.